Ticker League

Climb Bio (CLYM) Profit Bridge

See what drove Climb Bio's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

Analysis
Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

TTM

Revenue YoY

Operating Income YoY

+41.12%

Net Income YoY

+43.20%

Net Margin Δ

Net income bridge for Climb Bio (CLYM) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: $40.2M+43.20%

Profit bridge breakdown for Climb Bio (CLYM) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income-$93M
  • Revenue$0.00
  • Cost of Revenue-$106K
  • Operating Expenses$42.1M
  • Other Income / Expense-$1.77M
  • Income Tax$0.00
  • Net Loss-$52.8M
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation